D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 29,756 523 World Ranking 5948 National Ranking 250

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Schizophrenia
  • Psychiatry

Gary Remington focuses on Schizophrenia, Psychiatry, Psychosis, Antipsychotic and Internal medicine. His Schizophrenia study frequently draws connections to adjacent fields such as Psychopathology. His Psychiatry study typically links adjacent topics like Clinical psychology.

His study looks at the intersection of Psychosis and topics like Neuroscience with Anticipation. His Antipsychotic research incorporates themes from Risperidone, Dopamine receptor D2, Clinical trial and Polypharmacy. His biological study spans a wide range of topics, including Endocrinology and Atypical antipsychotic.

His most cited work include:

  • Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia (820 citations)
  • A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. (722 citations)
  • Serotonin-dopamine interaction and its relevance to schizophrenia (707 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Schizophrenia, Psychiatry, Antipsychotic, Internal medicine and Clinical psychology. His study in Schizophrenia is interdisciplinary in nature, drawing from both Psychosis, Psychopathology and Cognition. Much of his study explores Psychiatry relationship to Quality of life.

His Antipsychotic research is multidisciplinary, incorporating elements of Tardive dyskinesia, Dopamine receptor D2, Olanzapine, Risperidone and Pharmacology. His studies deal with areas such as Anesthesia, Endocrinology and Atypical antipsychotic as well as Internal medicine. He has included themes like Life satisfaction and Depression in his Clinical psychology study.

He most often published in these fields:

  • Schizophrenia (67.98%)
  • Psychiatry (51.77%)
  • Antipsychotic (38.56%)

What were the highlights of his more recent work (between 2017-2021)?

  • Schizophrenia (67.98%)
  • Internal medicine (37.33%)
  • Antipsychotic (38.56%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Schizophrenia, Internal medicine, Antipsychotic, Endocrinology and Clozapine. His Schizophrenia research is multidisciplinary, incorporating perspectives in Psychosis, Cognition and Clinical psychology. His Psychosis study is related to the wider topic of Psychiatry.

His studies in Internal medicine integrate themes in fields like Oncology and Cardiology. His work in Antipsychotic covers topics such as Pharmacogenetics which are related to areas like Bioinformatics and Allele. The concepts of his Clozapine study are interwoven with issues in Working memory, Psychopathology, Muscarinic acetylcholine receptor and Acetylcholine receptor.

Between 2017 and 2021, his most popular works were:

  • Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia. (49 citations)
  • Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia. (49 citations)
  • Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study. (34 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Schizophrenia
  • Psychiatry

The scientist’s investigation covers issues in Schizophrenia, Antipsychotic, Internal medicine, Cognition and Psychosis. His Schizophrenia research integrates issues from Meta-analysis and Clinical psychology. His work carried out in the field of Antipsychotic brings together such families of science as Gold standard, Randomized controlled trial, Adverse effect and Tardive dyskinesia.

His work is dedicated to discovering how Internal medicine, Endocrinology are connected with Drug, In vivo and Prefrontal cortex and other disciplines. His work in Cognition tackles topics such as Amotivation which are related to areas like Psychiatry, Need for achievement, Brain size and Stepwise regression. The Psychosis study combines topics in areas such as First episode and Body mass index, Waist, Waist–hip ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

Shitij Kapur;Robert Zipursky;Corey Jones;Gary Remington.
American Journal of Psychiatry (2000)

1274 Citations

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Guy Chouinard;Barry Jones;Gary Remington;David Bloom.
Journal of Clinical Psychopharmacology (1993)

1164 Citations

Serotonin-dopamine interaction and its relevance to schizophrenia

Shitij Kapur;Gary Remington.
American Journal of Psychiatry (1996)

1062 Citations

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

Shitij Kapur;Robert B. Zipursky;Gary Remington.
American Journal of Psychiatry (1999)

962 Citations

Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics

Claire H. Li;Robert E. Stratford;Nieves Velez de Mendizabal;Thomas I.F.H. Cremers.
Journal of Translational Medicine (2014)

620 Citations

Negative Symptoms in Schizophrenia: Avolition and Occam's Razor

George Foussias;George Foussias;Gary Remington;Gary Remington.
Schizophrenia Bulletin (2010)

585 Citations

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.

Shitij Kapur;Robert Zipursky;Corey Jones;C. S. Shammi.
Archives of General Psychiatry (2000)

512 Citations

Direct Activation of the Ventral Striatum in Anticipation of Aversive Stimuli

Jimmy Jensen;Anthony R McIntosh;Adrian P Crawley;David J Mikulis.
Neuron (2003)

505 Citations

5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation

Shitij Kapur;Robert B. Zipursky;Gary Remington;Corey Jones.
American Journal of Psychiatry (1998)

467 Citations

Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

Shitij Kapur;Shitij Kapur;Gary Remington.
Biological Psychiatry (2001)

461 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gary Remington

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 182

Shitij Kapur

Shitij Kapur

King's College London

Publications: 130

Christoph U. Correll

Christoph U. Correll

Charité - University Medicine Berlin

Publications: 112

John M. Kane

John M. Kane

Feinstein Institute for Medical Research

Publications: 87

Herbert Y. Meltzer

Herbert Y. Meltzer

Northwestern University

Publications: 68

Ariel Graff-Guerrero

Ariel Graff-Guerrero

Centre for Addiction and Mental Health

Publications: 68

Stefan Leucht

Stefan Leucht

Technical University of Munich

Publications: 65

Jeffrey A. Lieberman

Jeffrey A. Lieberman

Columbia University

Publications: 62

Ashok Malla

Ashok Malla

McGill University

Publications: 54

James H. MacCabe

James H. MacCabe

King's College London

Publications: 51

Brendon Stubbs

Brendon Stubbs

King's College London

Publications: 50

Robin M. Murray

Robin M. Murray

King's College London

Publications: 49

Philip D. Harvey

Philip D. Harvey

University of Miami

Publications: 47

Davy Vancampfort

Davy Vancampfort

KU Leuven

Publications: 46

Philip McGuire

Philip McGuire

King's College London

Publications: 46

Jim van Os

Jim van Os

University Medical Center Utrecht

Publications: 44

Trending Scientists

Axel Klar

Axel Klar

Technical University of Kaiserslautern

R Richard Nötzel

R Richard Nötzel

South China Normal University

Andreas Türler

Andreas Türler

University of Bern

Hans-Jörg Schneider

Hans-Jörg Schneider

Saarland University

Michael Reth

Michael Reth

University of Freiburg

Philippe Soriano

Philippe Soriano

Icahn School of Medicine at Mount Sinai

Emer Kennedy

Emer Kennedy

Teagasc - The Irish Agriculture and Food Development Authority

Jonathan Dushoff

Jonathan Dushoff

McMaster University

David P. Speert

David P. Speert

University of British Columbia

Spencer G. Lucas

Spencer G. Lucas

American Museum of Natural History

Marguerite A. Xenopoulos

Marguerite A. Xenopoulos

Trent University

David M. Farmer

David M. Farmer

University of Rhode Island

John O. Willoughby

John O. Willoughby

Flinders University

Essa Yacoub

Essa Yacoub

University of Minnesota

Nancy Folbre

Nancy Folbre

University of Massachusetts Amherst

Something went wrong. Please try again later.